Extravascular implantable cardioverter defibrillator insertion for preventing sudden cardiac death caused by ventricular arrhythmiaStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 8 April 2027
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke [TSID11920]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction [ID6514]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC